Key facts
- This page summarizes Johanna Mercier's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Sep 2026, 18:28.
Johanna Mercier - 10 Sep 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- Chief Comm & Corp Aff Officer
- Issuer ticker
- GILD
- Reported as of
- 10 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2026, 18:28:56 UTC
- Prior SEC filing
- 18 Aug 2026
- Next SEC filing
- 16 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Johanna Mercier
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Johanna Mercier filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 11 Sep 2026.
Change
- Previous filing in this sequence was filed on 18 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001782135
Primary reporting owner
Mercier Johanna
- Relationship
- Chief Comm & Corp Aff Officer
- Address
- GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Amy Kim by Power of Attorney for Johanna Mercier
- Signature date
- 11 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,797
- Change %
- +2.4%
- Price
- Shares after
- 121,031
- Date
- 10 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,347
- Change %
- -1.1%
- Price
- $144.81*
- Shares after
- 119,684
- Date
- 10 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -2,797
- Change %
- -10%
- Price
- Shares after
- 25,054
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,797
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.